Labelling Change Management Explained: Ultimate Guide to Regulatory Compliance and Lifecycle Updates

Labelling Change Management Explained: Ultimate Guide to Regulatory Compliance and Lifecycle Updates Mastering Labelling Change Management: Compliance-Ready Guide for Global Pharma Introduction to Labelling Change Management and Its Importance Labelling change management is the structured process of updating, controlling, and communicating changes to pharmaceutical product labels, including package inserts, patient leaflets, and carton/container artwork. It ensures that labelling reflects the latest clinical, safety, and regulatory information while maintaining compliance with agencies such as the FDA, EMA, CDSCO, and other national authorities. Labelling is a living document. From initial approval through post-marketing, labels must evolve to reflect new indications, safety warnings,…

Continue Reading... Labelling Change Management Explained: Ultimate Guide to Regulatory Compliance and Lifecycle Updates

TGA & PMDA Labelling Explained: Ultimate Guide to Regulatory Compliance in Australia and Japan

TGA & PMDA Labelling Explained: Ultimate Guide to Regulatory Compliance in Australia and Japan Mastering TGA and PMDA Labelling: Compliance-Driven Guide for Pharma Submissions Introduction to TGA & PMDA Labelling and Its Importance Labelling in Australia and Japan is regulated by the Therapeutic Goods Administration (TGA) and the Pharmaceuticals and Medical Devices Agency (PMDA) respectively. Both agencies ensure that drug labelling provides clear, accurate, and accessible information for healthcare professionals and patients. In Australia, labelling includes the Product Information (PI) and Consumer Medicine Information (CMI), while in Japan, it includes the Package Insert (PI) and patient-facing leaflets. These documents form…

Continue Reading... TGA & PMDA Labelling Explained: Ultimate Guide to Regulatory Compliance in Australia and Japan